Effectiveness of modified Valsalva maneuver by using wide bore syringe for emergency treatment of supraventricular tachycardias: Findings from Pakistan

Background and Objectives: The Valsalva maneuver (VM) is the most effective measure that can be carried out to treat supraventricular tachycardia (SVT). Our objective was to compare the efficacy of postural modified VM with 20 ml syringe to standard VM for the emergency treatment of SVT. Methods: This randomized control trial study was conducted at the Accident and Emergency Department, Pakistan ordinance factories hospital, Wah Cantt from July 2019 to September 2020. In the standard Valsalva group, fifty patients were placed at an angle of 45 with continuous monitoring of vitals and electrocardiogram. Patients blew into a 20ml syringe to generate 40 mmHg pressure for 15 seconds and remained in the same position for 45 seconds before a reassessment of cardiac rhythm at one-minute and three-minute intervals. In the modified Valsalva group same procedure was repeated with the other fifty patients, but immediately at the end of the strain, they were laid flat with their legs raised to 45° for 15 seconds. Participants returned to semi-recumbent position and cardiac rhythm was reassessed after 45 seconds and then at one and three minutes. Results: In the standard Valsalva maneuver (SVM)20.0% of participants versus 58% of participants in the modified Valsalva maneuvers group(MVM) reverted to sinus rhythm at one min (odds ratio or 5.52, 95% CI 2.26-13.47; p<0.001) and time of stay in the emergency room was (odds ratio or 2.39, 95% CI 1.45- 3.93; p<0.0001). Conclusion: Modified Valsalva by using a wide-bore syringe is more effective method than standard Valsalva in terminating SVT.

[1]  Yen-Ta Huang,et al.  Comparison of Various Vagal Maneuvers for Supraventricular Tachycardia by Network Meta-Analysis , 2022, Frontiers in Medicine.

[2]  Zheng Zhang,et al.  Modified Valsalva maneuver for treatment of supraventricular tachycardias: A Meta-analysis. , 2021, The American journal of emergency medicine.

[3]  A. Ghaddaf,et al.  Modified valsalva versus standard valsalva for cardioversion of supraventricular tachycardia: systematic review and meta-analysis , 2021, International Journal of Arrhythmia.

[4]  Wei Wang,et al.  Efficacy and economic benefits of a modified Valsalva maneuver in patients with paroxysmal supraventricular tachycardia , 2020, World journal of clinical cases.

[5]  T. Tam,et al.  A multicenter randomized controlled trial of a modified Valsalva maneuver for cardioversion of supraventricular tachycardias. , 2020, The American journal of emergency medicine.

[6]  Steven E. Williams,et al.  Supraventricular tachycardia: An overview of diagnosis and management. , 2020 .

[7]  S. Asirvatham,et al.  Supraventricular Arrhythmias: Clinical Framework and Common Scenarios for the Internist , 2018, Mayo Clinic proceedings.

[8]  Salih Ekinci,et al.  Valsalva maneuver techniques for supraventricular tachycardias: Which and how? , 2017 .

[9]  E. Akıncı,et al.  Comparing the success rates of standard and modified Valsalva maneuvers to terminate PSVT: A randomized controlled trial , 2017, The American journal of emergency medicine.

[10]  V. Essebag,et al.  Diagnosis and management of supraventricular tachycardias , 2016, Canadian Medical Association Journal.

[11]  F. Cosío,et al.  European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  Samantha Taylor The Valsalva manoeuvre: does syringe size really matter? , 2016 .

[13]  T. Coats,et al.  Valsalva using a syringe: pressure and variation , 2016, Emergency Medicine Journal.

[14]  T. Lobban,et al.  Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial , 2015, The Lancet.

[15]  A. Appelboam,et al.  Modified Valsalva manoeuvre to treat recurrent supraventricular tachycardia: description of the technique and its successful use in a patient with a previous near fatal complication of DC cardioversion , 2014, BMJ Case Reports.

[16]  J. Almendral,et al.  Paroxysmal Supraventricular Tachycardias and Preexcitation Syndromes , 2012 .

[17]  S. Z. Jamal,et al.  Cardiac electrophysiology studies and ablations for treatment of supraventricular arrhythmias--an initial experience from Karachi. , 2011, JPMA. The Journal of the Pakistan Medical Association.

[18]  S. Walker,et al.  Impact of a modified Valsalva manoeuvre in the termination of paroxysmal supraventricular tachycardia , 2010, Emergency Medicine Journal.

[19]  M. Boyle,et al.  The 10 mL syringe is useful in generating the recommended standard of 40 mmHg intrathoracic pressure for the Valsalva manoeuvre , 2009, Emergency Medicine Australasia.

[20]  S. Z. Jamal,et al.  Cardiac electrophysiologic procedures - A ten years' experience at National Institute of Cardiovascular Diseases, Karachi. , 2019, JPMA. The Journal of the Pakistan Medical Association.

[21]  J. T. Wheeler Modified Valsalva Maneuver vs. Standard Valsalva Maneuver on Emergency Department Patients Presenting with Supraventricular Tachycardia , 2016 .

[22]  D. Taylor,et al.  Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia. , 2013, The Cochrane database of systematic reviews.